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The Canadian Hypertension Education Program (CHEP)
started an ambitious dissemination and implementation
program (D&I) in 1999 [1]. Recent data show that con-
trol of hypertension in Canada has recently improved
dramatically from 13% in 1992 [2] to 66% in 2008 [3-5].
Improved hypertension control from survey data is sup-
ported by and consistent with the data of declining
Canadian standardized yearly mortality and hospitaliza-
tion rates for the complications of hypertension - stroke,
heart failure and acute myocardial infarction [5,6]. This
achievement makes Canada a world leader in treatment
and control of hypertension.
CHEP’s D&I program includes three components: dis-
semination, implementation and addressing barriers.
Dissemination has been achieved through a passive-to-
active dissemination process by publishing in multiple
formats - peer-reviewed and non peer-reviewed - with
content tailored to end users, including patients and
their families. Another important aspect has been the
development of tools to help professionals in daily deci-
sion making for the management of hypertension [1].
Implementation happens when the information is used
locally and barriers to the translation of such information
are addressed. Characteristics of D&I programs usually
include the following elements: multifaceted, multiple
audiences, multimedia, consistent information and mes-
sages; sustainable, credible, using the appropriate language,
and realistic and applicable. Each barrier is specific and
should be addressed individually. A barrier can be, for
example, related to access to professional services, diag-
nostic procedures, specific therapeutic procedures or
different provincial/local regulations. Some barriers may
be local or systemic (for example salt/sodium added in
processed food) or absence of structured care in the man-
agement of chronic diseases.
In our experience, critical success factors for guidelines
implementation are: a strong methodology for the devel-
opment of high quality recommendations, an annual
review of the scientific literature, and endorsement and
participation of leading experts and key opinion leaders.
Items listed on Table 1 can probably explain CHEP’s
success.
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Table 1
Branding of CHEP
An Implementation Task Force
A 5-year Business Plan
An endowed chair for “Knowledge Translation on Hypertension” to
spearhead, coordinate, facilitate and maintain the process
A yearly revision/dissemination process
An Outcomes Research Task Force.
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